Logo

Roche Files Suit Against Enzo After Offer to Settle Falls Through

Jun 03, 2004

NEW YORK, June 3 (GenomeWeb News) - Roche Diagnostics and Roche Molecular Systems are suing Enzo Biochem and Enzo Life Sciences to strike down Enzo's claims to  microarray-related technologies, Enzo said today. The suit was filed after Enzo rejected a cash settlement offer from Roche as inadequate.

 

Enzo said it "will vigorously protect its assets and rights and will respond appropriately to this action."

 

Enzo claims that Roche broke a distribution and supply agreement the two companies signed in 1994, and that certain products and technologies "that were funneled by Affymetrix Inc. to Roche" belong to Enzo under an agreement the company has with Affymetrix.

 

The disputed technology relates to Enzo's US patent 4,994,373,  "Method and structures employing chemically-labelled polynucleotide probes", which is also the subject of a lawsuit by Enzo against Affymetrix.

Breaking News
The Scan

CDC Calls Delta "Variant of Concern"

CNN reports the US Centers for Disease Control and Prevention now considers the Delta variant of SARS-CoV-2 to be a "variant of concern."

From FDA to Venture Capital

Former FDA Commissioner Stephen Hahn is taking a position at a venture capital firm, leading some ethicists to raise eyebrows, according to the Washington Post.

Consent Questions

Nature News writes that there are questions whether informed consent was obtained for some submissions to a database of Y-chromosome profiles.

Cell Studies on Multimodal Single-Cell Analysis, Coronaviruses in Bats, Urban Microbiomes

In Cell this week: approach to analyze multimodal single-cell genomic data, analysis of bat coronaviruses, and more.